Home
>
National Drug Code (NDC)
>
LASTACAFT
LASTACAFT - 0023-4290-03 - (alcaftadine)
Drug Information of LASTACAFT
| Product NDC: | 0023-4290 |
| Proprietary Name: | LASTACAFT |
| Non Proprietary Name: | alcaftadine |
| Active Ingredient(s): | 2.5 mg/mL & nbsp; alcaftadine |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LASTACAFT
| Product NDC: | 0023-4290 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022134 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101101 |
Package Information of LASTACAFT
| Package NDC: | 0023-4290-03 |
| Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-03) > 3 mL in 1 BOTTLE, PLASTIC |
NDC Information of LASTACAFT
| NDC Code | 0023-4290-03 |
| Proprietary Name | LASTACAFT |
| Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0023-4290-03) > 3 mL in 1 BOTTLE, PLASTIC |
| Product NDC | 0023-4290 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alcaftadine |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20101101 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | ALCAFTADINE |
| Strength Number | 2.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
